Clinical Trials Sponsored by Mercer University

Total 225952 results

Laval University
Merck Sharp & Dohme LLC

Completed

Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes

Diabetes Mellitus | Postprandial Lipemia

Canada
Columbia University
Merck Sharp & Dohme LLC

Completed

Acceptance of Human Papillomavirus Vaccination in Postpartum Women (HPV Acceptance)

HPV | Human Papilloma Virus | Post Partum

United States
Columbia University
Merck Sharp & Dohme LLC

Withdrawn

The Effects of Alendronate After Cure of Primary Hyperparathyroidism (AlenPostPara)

Hyperparathyroidism

United States
Jagiellonian University
Merck Sharp & Dohme LLC

Unknown

Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects

Acute Coronary Syndrome

Poland
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Completed

Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone (SGA)

Infant, Small for Gestational Age

Spain
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain (ECOS ESP)

Growth Disorders

Spain
Merck KGaA, Darmstadt, Germany
Merck Ltd., India

Terminated

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Carcinoma, Squamous Cell

India
Merck KGaA, Darmstadt, Germany
Merck Ltd., Thailand

Terminated

Glucophage XR® Observational Study

Diabetes Mellitus Type 2 | GI Side Effect

Thailand
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Withdrawn

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets

Diabetes Mellitus Type 2
Columbia University
Merck Sharp & Dohme LLC

Not yet recruiting

Efficacy of Suvorexant on Post-operative Sleep Disturbance

Postoperative Delirium | Postoperative Insomnia

United States
Columbia University
Merck Sharp & Dohme LLC

Recruiting

ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases

COVID-19 | Households | SARS CoV 2 Infection

United States
Heidelberg University
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH (ESRA)

Systemic Sclerosis | Pulmonary Vascular Disorder | Primary Pulmonary Hypertension | Other Systemic Involvement of Connective Tissue

Austria, Germany, Italy, France, Switzerland
Fudan University
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004) (HYPERION)

Esophageal Squamous Cell Carcinoma

China
Fudan University
Merck Sharp & Dohme LLC

Recruiting

Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients

Triple Negative Breast Cancer

China
Columbia University
Merck Sharp & Dohme LLC

Recruiting

Stick2PrEP Cisgender Women and Trans Individuals (S2P:CWTI)

HIV Prevention | Pre-exposure Prophylaxis

United States
Yale University
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma

Melanoma | Renal Cell Carcinoma | Metastatic Melanoma | Brain Metastases | Pembrolizumab | Lenvatinib | PD1/PD-L1 Experienced

United States
Georgetown University
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

Cervical Cancer | Metastatic Cervical Cancer

United States
Stanford University
Merck Sharp & Dohme LLC

Recruiting

Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma

Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Relapsed Classical Hodgkin Lymphoma

United States
Stanford University
Merck Sharp & Dohme LLC

Active, not recruiting

Ertugliflozin: Cardioprotective Effects on Epicardial Fat

Cardiovascular Diseases | Atherosclerosis | Insulin Resistance | Type 2 Diabetes

United States
Columbia University
Merck Sharp & Dohme LLC

Completed

Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods

Covid19 | Vaccine Acceptability

United States
Merve Sevgi INCE

Completed

Critical Shoulder Angle and Acromial Index on 3D Models

Rotator Cuff Injuries | Shoulder Injuries | Rotator Cuff Tears

Turkey
Yale University
Merck Sharp & Dohme LLC

Terminated

Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas

Relapsed Lymphomas | Refractory Lymphomas

United States
Yale University
Merck Sharp & Dohme LLC

Completed

Sugammadex and Decreased Time to Extubation

Coronary Artery Bypass Graft and/or Aortic Valve Replacement Surgery

United States
Columbia University
Merck Sharp & Dohme LLC

Completed

Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies (SAHA)

Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States
Johns Hopkins University
Mercy Medical Center

Completed

Shaping Anesthetic Techniques to Reduce Post-operative Delirium (SHARP)

Delirium | Lumbar Radiculopathy | Lumbar Osteoarthritis | Lumbar Spine Disc Degeneration

United States
Laval University
Merck Sharp & Dohme LLC

Completed

Sitagliptin Therapy and Kinetics of Inflammatory Markers

Type 2 Diabetes Mellitus

Canada
Northwestern University
Merck Sharp & Dohme LLC

Completed

Promoting the Universal Medication Schedule Via Mobile and EHR Technologies

Type 2 Diabetes

United States
McMaster University
Merck Sharp & Dohme LLC

Completed

Zoster Vaccine Response in the Frail Elderly

Immune System Diseases

Canada
Heidelberg University
Merck Sharp & Dohme LLC

Completed

Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS) (SAHA-I)

Soft Tissue Sarcoma

Germany
Duke University
Merck Sharp & Dohme LLC

Completed

Transplantation and the Use of Raltegravir in HIV-Infected Patients

HIV Positive | Organ Transplant Recipient | Active Wait Listing for Organ Transplant

United States
Georgetown University
Merck Sharp & Dohme LLC

Terminated

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

Type II Diabetes

United States
Laval University
Merck Sharp & Dohme LLC

Completed

Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes (JANUB48)

Type 2 Diabetes Mellitus

Canada
Zhejiang University
Merck Sharp & Dohme LLC

Unknown

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Lung Cancer | Chemotherapy-Induced Nausea and Vomiting

China
Osaka University
Merck Sharp & Dohme LLC

Unknown

Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia (INFINITY)

Hyper-LDL-cholesterolemia | Low CETP Activity | CETP Deficiency | Hyperalphalipoproteinemia | High Level of Remnant Cholesterol

Japan
Laval University
Merck Serono International SA

Unknown

Control Ovarian Stimulation Timing Test (COST2)

Infertility

Canada
Drexel University
Merck Sharp & Dohme LLC

Completed

Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting

Nausea | Vomiting

United States
Indiana University
Merck Sharp & Dohme LLC

Unknown

Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers

Human Papillomavirus Infection

United States
Vietnam National University
Merck Serono Vietnam

Completed

Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study

Infertility

Vietnam
Heidelberg University
Merck KGaA, Darmstadt, Germany

Unknown

Paclitaxel/Carboplatin With or Without Cetuximab in CUP (PACET-CUP)

Carcinoma | Neoplasms, Unknown Primary

Germany
mads u werner
University of Kentucky

Completed

Effect of High-dose Naloxone Following Third Molar Extraction (TME)

Pain, Acute | Healthy Subjects | Hyperalgesia | Sensitization, Central | Inflammations, Endodontic

Denmark
Merck KGaA, Darmstadt, Germany
Merck B.V., Netherlands

Terminated

MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS) (MESTRE-MS)

Multiple Sclerosis

Germany
Merck KGaA, Darmstadt, Germany
Merck S.A. Columbia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia (ECOS COL)

Growth Disorders

Colombia
Merck KGaA, Darmstadt, Germany
Merck A.B., Sweden

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden (ECOS SWE)

Growth Disorders

Sweden
Merck KGaA, Darmstadt, Germany
Merck Ltd., India

Terminated

A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (PMS LAD SCCHN)

Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck | LA SCCHN

India
Merck KGaA, Darmstadt, Germany
Merck Inc., Philippines

Completed

A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes

Hypertension

Philippines
Merck KGaA, Darmstadt, Germany
Merck Kft., Hungary

Completed

An Observational Study to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation in Assisted Reproductive Techniques (ESCORT)

Infertility

Hungary
Merck KGaA, Darmstadt, Germany
Merck d.o.o., Serbia

Completed

A Post Marketing Assessment of Gonal f Solution for Injection in a Prefilled Pen for Follicular Stimulation in in Vitro Fertilisation/Embryo Transfer (IVF-ET) Cycles (POINT)

Infertility

Serbia
Merck KGaA, Darmstadt, Germany
Merck Serono Norway

Completed

A Phase IV, Prospective, Observational, Open Label, Single Centre Cohort Trial to be Conducted in Norway During One Year to Assess the Cumulative Pregnancy Rate in a New Series of In-vitro Fertilization (IVF) Treatment Cycles Following Three or More Previous IVF Treatment Cycles Without Live Birth

Infertility

Norway
mads u werner
University of Kentucky

Completed

Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia During a Burn Injury (TCI-NX-BI)

Healthy Subjects

Denmark
Merck KGaA, Darmstadt, Germany
Merck Ltd., Taiwan; Merck Pte. Ltd., Singapore; PT Merck Tbk., Indonesia, an...

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore) (ECOS TW ID SG)

Growth Disorders

Singapore, Taiwan, Indonesia

Clinical Trials Sponsored by Mercer University

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations